The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

Starting in 2026, Medicare will implement a $2,000 annual cap on out-of-pocket drug spending. This change is in the Inflation ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

The federal government says it has struck a deal to dramatically lower prices on 15 widely used medications covered by ...

The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027.

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

Medicare Part D and Medicare Advantage are undergoing some of their most consequential shifts in years, and the 2025 plan ...

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...